Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pul… Read more
Neuronetics Inc (STIM) - Total Assets
Latest total assets as of September 2025: $145.47 Million USD
Based on the latest financial reports, Neuronetics Inc (STIM) holds total assets worth $145.47 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Neuronetics Inc - Total Assets Trend (2016–2024)
This chart illustrates how Neuronetics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Neuronetics Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Neuronetics Inc's total assets of $145.47 Million consist of 41.3% current assets and 58.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.8% |
| Accounts Receivable | $24.29 Million | 17.2% |
| Inventory | $4.25 Million | 3.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $19.61 Million | 13.9% |
| Goodwill | $18.63 Million | 13.2% |
Asset Composition Trend (2016–2024)
This chart illustrates how Neuronetics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Neuronetics Inc's current assets represent 41.3% of total assets in 2024, a decrease from 92.4% in 2016.
- Cash Position: Cash and equivalents constituted 13.8% of total assets in 2024, down from 68.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 17.2% of total assets.
Neuronetics Inc Competitors by Total Assets
Key competitors of Neuronetics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Neuronetics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Neuronetics Inc generates 0.53x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Neuronetics Inc is currently not profitable relative to its asset base.
Neuronetics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.24 | 3.16 | 4.75 |
| Quick Ratio | 2.09 | 2.87 | 4.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $35.95 Million | $ 36.56 Million | $ 51.33 Million |
Neuronetics Inc - Advanced Valuation Insights
This section examines the relationship between Neuronetics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.98 |
| Latest Market Cap to Assets Ratio | 0.37 |
| Asset Growth Rate (YoY) | 21.6% |
| Total Assets | $140.90 Million |
| Market Capitalization | $52.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Neuronetics Inc's assets below their book value (0.37 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Neuronetics Inc's assets grew by 21.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Neuronetics Inc (2016–2024)
The table below shows the annual total assets of Neuronetics Inc from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $140.90 Million | +21.65% |
| 2023-12-31 | $115.83 Million | -0.90% |
| 2022-12-31 | $116.88 Million | -17.23% |
| 2021-12-31 | $141.22 Million | +79.54% |
| 2020-12-31 | $78.66 Million | -21.47% |
| 2019-12-31 | $100.17 Million | -14.40% |
| 2018-12-31 | $117.02 Million | +200.53% |
| 2017-12-31 | $38.94 Million | +57.02% |
| 2016-12-31 | $24.80 Million | -- |